On Tuesday, InnoCare Pharma Limited (9969.HK), a biopharmaceutical company, received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to ...
A 2024 protocol published in BMJ Open, outlining a planned systematic review to quantify that excess burden worldwide, noted ...
Magda Szubanski opens up about her cancer recovery, the difficult family truths behind her new memoir and the love that ...
"You have to advocate for yourself, even if it’s hard and you’re getting talked over by 'the experts.' You know your body; listen to what it’s telling you." ...
An Australian-built app is giving Hodgkin lymphoma survivors a way to report the long-term effects of treatment – including ...
AbbVie has an average rating of overweight and mean price target of $281.54, according to analysts polled by FactSet.
Magda Szubanski is continuing to travel and live her life to the fullest despite battling an 'incurable' cancer.
A phase 2 clinical trial has delivered some of the most striking results yet reported in early-stage classical Hodgkin lymphoma, showing that a regimen pairing two targeted drugs with a stripped-down ...
Cutaneous lymphoma is often a chronic disease that can be managed for many years, and prognosis (chance of recovery) depends on the specific type, stage and how the disease behaves over time. Some ...
Szubanski, 65, has been battling Mantle Cell Lymphoma, a rare and aggressive blood cancer, since May last year. In February, she announced she was in remission. Appearing on 60 Minutes – marking her ...
Magda Szubanski has opened up about her incurable cancer diagnosis in a candid interview – the first public one since her diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results